About Octamer
Octamer is a company based in Grafelfing (Germany) founded in 2018 was acquired by Volition in December 2019. Octamer operates in a competitive market with competitors including Neogen, Parse Biosciences, Qiagen, Biofidelity and Fluent BioSciences, among others.
- Headquarter Grafelfing, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Octamer
Detailed funding history for Octamer
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Octamer
Octamer has secured backing from 1 investor. Prominent investors backing the company include Volition.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Volition is focused on developing epigenetic diagnostic solutions.
|
Locked | Locked | Locked |
Investor details for Octamer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Octamer
Investment portfolio details for Octamer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Octamer
Detailed financials for Octamer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Octamer Comparisons
Peer comparison for Octamer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Octamer
Octamer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Parse Biosciences, Qiagen, Biofidelity and Fluent BioSciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Proprietary reagents for single-cell genetic analysis are developed.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
Detailed competitors of Octamer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Octamer
Complete news archive for Octamer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Octamer
Octamer was founded in 2018.
Octamer is headquartered in Grafelfing, Germany. It is registered at Grafelfing, Bavaria, Germany.
Octamer was founded in 2018 in Grafelfing, Germany, where operations center on the biotechnology sector. Screening substrates tailored for epigenetics research are offered, encompassing histones, nucleosomes, histone octamers, and DNA templates. Nucleosomes serve as control reagents in applications such as mode of action studies, biophysical profiling, and structural biology. The focus remains on supporting research needs in this specialized field.
Octamer's top competitors include Neogen, Qiagen and Parse Biosciences.
Octamer has 1 investor. Key investors include Volition.